Business ❯Healthcare ❯Pharmaceuticals ❯Weight Loss Drugs

Novo Nordisk

Novo Nordisk CEO Steps Down Following Share Price Collapse

Lars Fruergaard Jørgensen will remain temporarily to ensure a smooth transition as the company faces intensified competition and market pressures.

Domino's Faces Mixed Earnings Report with U.S. Sales Lagging Expectations

Eli Lilly's Q2 Earnings Surge on High Demand for Weight-Loss Drugs

Roche Accelerates Development of Promising Weight-Loss Pills